Skipping doses enhances the threat of treatment failure. Be sure that you take all your doses at the proper time.HIV-one infected subjects on dolutegravir monotherapy demonstrated immediate and dose-dependent reduction of antiviral activity with declines of HIV-1 RNA copies for every ml. The antiviral response was maintained for three to four days